GE Healthcare’s parent company has had a rough run lately. The corporate giant has lost half its value in 2017—and another 25 percent this year. GE was also delisted from the Dow Jones Industrial Average. But Monday’s news that GE would spin off its healthcare division into a separate company could provide freedom for the standalone.

As overdiagnosis is increasingly recognized in the realm of cancer care, the term itself might benefit from a simpler, standardized definition, a group of researchers argue in an Annals of Internal Medicine editorial published this June.

Robert Wilkie appeared before the Senate Committee on Veterans Affairs (VA) for his confirmation hearing to be Secretary of the Department of the VA on Wednesday—three months after President Donald Trump fired then-VA Secretary David Shulkin.

Many adult survivors of childhood cancer are not concerned about their future health or developing new cancers, according to a new study published in Cancer.

A federal jury awarded a patient and her husband $15 million after Carmel, Indiana, physicians reportedly failed to identify a life-threatening tumor during a CT scan, the Indianapolis Business Journal has reported.

It’s not every day that imaging equipment is used to scan a 68-million-year-old dinosaur skull, but that’s exactly what happened at George Washington University in Washington, D.C.

Zipnosis, providers of virtual care software, has been certified by Surescripts to add medication history services to its virtual care platform.

A company called Novoheart has created the first 3D heart organoid—a miniature version of the real thing—which contains a hollow chamber similar to one of the four in a normal human heart. According to a story published by Wired, these mini-hearts could be used to test the effects of drug treatments before expensive human trials are necessary.